The WYZ-1 mouse glioblastoma stem cell model: A novel preclinical tool for tumor and therapy studies
Open Access
- 10 June 2026
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 656, 218668
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- U.S. Department of Health and Human Services
- National Cancer Institute (ZIA BC 011773)
This publication has 36 references indexed in Scilit:
- Molecular drivers of epithelial-mesenchymal transition (EMT) in glioblastoma and impact on therapy resistancePathology - Research and Practice, 2025
- Tumor heterogeneity and resistance in glioblastoma: the role of stem cellsApoptosis, 2025
- An Integrative Model of Cellular States, Plasticity, and Genetics for GlioblastomaCell, 2019
- Importance of GFAP isoform‐specific analyses in astrocytomaGlia, 2019
- Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant GliomaCancer Cell, 2016
- A neurocentric perspective on glioma invasionNature Reviews Neuroscience, 2014
- Patient-Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas In SituCell Reports, 2013
- Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 modelCancer Immunology, Immunotherapy, 2010
- Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic ScreensCell Stem Cell, 2009
- Identification of human brain tumour initiating cellsNature, 2004